CoChat

Comparison of two neoadjuvant chemoradiotherapy regimens in patients with potentially curable esophageal carcinoma: Chemoradiotherapy in esophageal cancer

Blom, R. L. G. M., Sosef, M. N., Nap, M., Lammering, G., van den Berkmortel, F., Hulshof, M. C. C. M., Meijer, S. L., Wilmink, H. W., van Berge Henegouwen, M. I. · 2014 · Diseases of the Esophagus
Cited by 39

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/dote.12110

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 23

  1. Devesa, 1998, Changing patterns in the incidence of esophageal and gastric carcinoma in the United States, Cancer, 83, 2049, 10.1002/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.0.CO;2-2 · DOI · Paper page
  2. Pohl, 2005, The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence, J Natl Cancer Inst, 97, 142, 10.1093/jnci/dji024 · DOI · Paper page
  3. Hulscher, 2002, Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus, N Engl J Med, 347, 1662, 10.1056/NEJMoa022343 · DOI · Paper page
  4. Sjoquist, 2011, Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis, Lancet Oncol, 12, 681, 10.1016/S1470-2045(11)70142-5 · DOI · Paper page
  5. Ajani, 2008, Optimizing docetaxel chemotherapy in patients with cancer of the gastric and gastroesophageal junction: evolution of the docetaxel, cisplatin, and 5-fluorouracil regimen, Cancer, 113, 945, 10.1002/cncr.23661 · DOI
  6. Minsky, 2002, INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy, J Clin Oncol, 20, 1167, 10.1200/JCO.20.5.1167 · doi:10.1200/jco.20.5.1167 · Paper page
  7. Hagen, 2012, Preoperative chemoradiotherapy for esophageal or junctional cancer, N Engl J Med, 366, 2074, 10.1056/NEJMoa1112088 · DOI · Paper page
  8. Heijl, 2008, Neoadjuvant chemoradiation followed by surgery versus surgery alone for patients with adenocarcinoma or squamous cell carcinoma of the esophagus (CROSS), BMC Surg, 8, 21, 10.1186/1471-2482-8-21 · DOI
  9. Trotti, 2003, CTCAE V3.0: development of a comprehensive grading system for the adverse effects of cancer treatment, Semin Radiat Oncol, 13, 176, 10.1016/S1053-4296(03)00031-6 · DOI · Paper page
  10. Sobin, 2002, International Union against Cancer. TNM: Classification of Malignant Tumours
  11. Chirieac, 2005, Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation, Cancer, 103, 1347, 10.1002/cncr.20916 · DOI · Paper page
  12. Ancona, 2001, Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone, Cancer, 91, 2165, 10.1002/1097-0142(20010601)91:11<2165::AID-CNCR1245>3.0.CO;2-H · DOI · Paper page
  13. Burmeister, 2005, Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial, Lancet Oncol, 6, 659, 10.1016/S1470-2045(05)70288-6 · DOI · Paper page
  14. Burmeister, 2011, Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trial, Eur J Cancer, 47, 354, 10.1016/j.ejca.2010.09.009 · DOI · Paper page
  15. Cunningham, 2006, Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer, N Engl J Med, 355, 11, 10.1056/NEJMoa055531 · DOI · Paper page
  16. Walsh, 1996, A comparison of multimodal therapy and surgery for esophageal adenocarcinoma, N Engl J Med, 335, 462, 10.1056/NEJM199608153350702 · DOI · Paper page
  17. Ychou, 2011, Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial, J Clin Oncol, 29, 1715, 10.1200/JCO.2010.33.0597 · DOI · Paper page
  18. Herskovic, 1992, Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus, N Engl J Med, 326, 1593, 10.1056/NEJM199206113262403 · DOI · Paper page
  19. Meerten, 2006, Neoadjuvant concurrent chemoradiation with weekly paclitaxel and carboplatin for patients with oesophageal cancer: a phase II study, Br J Cancer, 94, 1389, 10.1038/sj.bjc.6603134 · DOI
  20. Bosset, 1997, Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus, N Engl J Med, 337, 161, 10.1056/NEJM199707173370304 · DOI · Paper page
  21. Lee, 2004, A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma, Ann Oncol, 15, 947, 10.1093/annonc/mdh219 · DOI · Paper page
  22. Stahl, 2009, Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction, J Clin Oncol, 27, 851, 10.1200/JCO.2008.17.0506 · DOI · Paper page
  23. Gebski, 2007, Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis, Lancet Oncol, 8, 226, 10.1016/S1470-2045(07)70039-6 · DOI · Paper page

Cited by

See all 39

Metadata

Authors
Blom, R. L. G. M., Sosef, M. N., Nap, M., Lammering, G., van den Berkmortel, F., Hulshof, M. C. C. M., Meijer, S. L., Wilmink, H. W., & van Berge Henegouwen, M. I.
Affiliations
  • Department of Surgery; Academic Medical Center; Amsterdam
  • Department of Surgery; Atrium Medical Center; Heerlen
  • Department of Pathology; Atrium Medical Center; Heerlen
  • Department of Radiation Oncology; MAASTRO; Maastricht the Netherlands
  • Department of Internal Medicine and Gastroenterology; Academic Medical Center; Amsterdam
  • Department of Radiation Oncology; Academic Medical Center; Amsterdam
  • Department of Pathology; Academic Medical Center; Amsterdam
  • Department of Medical Oncology; Academic Medical Center; Amsterdam
Venue
Diseases of the Esophagus
Published
2013-09-05
Volume
27
Issue
4
Pages
380-387
ISSN
1120-8694
Cited by
39
References
1
Language
en
Licence
doi.wiley.com/10.1002/tdm_license_1 (tdm, 726 d)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comparison of two neoadjuvant chemoradiotherapy regimens in patients with potentially curable esophageal carcinoma: Chemoradiotherapy in esophageal cancer. https://app.cochat.ai/papers/10.1111/dote.12110
The paper
Blom, R. L. G. M., Sosef, M. N., Nap, M., Lammering, G., van den Berkmortel, F., Hulshof, M. C. C. M., Meijer, S. L., Wilmink, H. W., & van Berge Henegouwen, M. I. (2014). Comparison of two neoadjuvant chemoradiotherapy regimens in patients with potentially curable esophageal carcinoma: Chemoradiotherapy in esophageal cancer. Diseases of the Esophagus. https://doi.org/10.1111/dote.12110

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.